Abstract |
Prodigiosin is a red pigment produced by Serratia marcescens with anticancer, antimalarial, and antibacterial effects. In this study, we extracted and identified a red pigment from a culture of S. marcescens strain ZPG19 and investigated its effect on the growth performance and intestinal microbiota of Kunming mice. High-performance liquid chromatography/mass spectrometry revealed that the pigment had a mass-to-charge ratio (m/z) of 324.2160, and thus it was identified as prodigiosin. To investigate the effect of prodigiosin on the intestinal microbiota, mice (n = 5) were administered 150 μg/kg/d prodigiosin ( crude extract, 95% purity) via the drinking water for 18 days. Administration of prodigiosin did not cause toxicity in mice. High-throughput sequencing analysis revealed that prodigiosin altered the cecum microbiota abundance and diversity; the relative abundance of Desulfovibrio significantly decreased, whereas Lactobacillus reuteri significantly increased. This finding indicates that oral administration of prodigiosin has a beneficial effect on the intestinal microbiota of mice. As prodigiosin is non-toxic to mouse internal organs and improves the mouse intestinal microbiota, we suggest that it is a promising candidate drug to treat intestinal inflammation.
|
Authors | Xue Li, Xinfeng Tan, Qingshuang Chen, Xiaoling Zhu, Jing Zhang, Jie Zhang, Baolei Jia |
Journal | Molecules (Basel, Switzerland)
(Molecules)
Vol. 26
Issue 8
(Apr 09 2021)
ISSN: 1420-3049 [Electronic] Switzerland |
PMID | 33918541
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Animals
- Biodiversity
- Body Weight
(drug effects)
- Fermentation
(drug effects)
- Gastrointestinal Microbiome
(drug effects)
- Metabolome
- Mice
- Organ Specificity
(drug effects)
- Phenotype
- Phylogeny
- Prodigiosin
(chemistry, pharmacology)
- Serratia marcescens
(chemistry, metabolism)
|